In a large-scale prospective study where 4,274 patients with acute ischemic stroke were enrolled, elevated levels of adiponectin were associated with increased risk for MACE within 3 years of follow-up [43], and similar results were shown in patients with metabolic syndrome [44], concomitant hemodialysis [45] or hypertension [46]. Here, ADIPOQ is linked to Hypertension.